Abstract
The term “quality of life” is widely used by psychologists, sociologists, economists, policy makers, and others. However, what is meant by quality of life varies greatly depending on the context. In some settings, it may include such components as employment status, income, housing, material possessions, environment, working conditions, or the availability of public services. The kinds of indices that reflect quality of life from a medical or health viewpoint are very different, and would include those aspects that might be influenced not only by conditions or diseases but also by medical treatment or other types of interventions. Thus, the term “health-related quality of life (HRQL)” is now commonly used to mean the measurement of one’s life quality from a health or medical perspective.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Quality of Life Assessment in Cancer Clinical Trials. Report of the Workshop on Quality of Life Research in Cancer Clinical Trials. USDHHS, Bethesda, Maryland, 1991.
Spilker B (ed.). Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996.
Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887–900.
Fairclough DL. Design and Analysis of Quality of Life Studies in Clinical Trials (Interdisciplinary Statistics). Boca Raton, Florida: Chapman & Hall/CRC, 2002.
Fayers P, Machin D. Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. Chichester: John Wiley & Sons, Ltd, 2007.
Ganz PA, Reeve BB, Clauser SB, Lipscomb J. Patient-reported outcomes assessment in cancer trials. J Clin Oncol 2007;25:5049–5141.
Stewart AL, Ware JE (eds.). Measuring Functioning and Well-Being. Durham, NC: Duke University Press, 1992.
Wilkin D, Hallam L, Doggett M. Measures of Need and Outcome for Primary Health Care. New York: Oxford Medical Publications, 1992.
McDowell I. Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press, 2006.
Berzon R, Hays RD, Shumaker SA. International use, application and performance of health-related quality of life instruments. Qual Life Res 1993;2:367–368.
Stewart A. Conceptual and methodologic issues in defining quality of life: State of the art. Prog Cardiovasc Nurs 1992;7:3–11.
Wenger NK, Furberg CD. Cardiovascular Disorders. In Spilker B (ed.). Quality of Life Assessment in Clinical Trials. New York: Raven Press, 1990.
Mossey JM, Shapiro E. Self-rated health: A predictor of mortality among the elderly. Am J Public Health 1982;72:800–808.
Kaplan GA, Camacho T. Perceived health and mortality: A nine-year follow-up of the human population laboratory cohort. Am J Epidemiol 1993;117:292–304.
Schron EB, Shumaker SA. The integration of health quality of life in clinical research: Experiences from cardiovascular clinical trials. Prog Cardiovasc Nurs 1992;7:21–28.
Sugarbaker PH, Barofsky I, Rosenberg SA, Gianola FJ. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery 1982;91:17–23.
The Women’s Health Initiative Study Group. Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61–109.
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321–333.
The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 2004;291:1701–1712.
Naughton MJ, Jones AS, Shumaker SA. When practices, promises, profits, and policies outpace hard evidence: The post-menopausal hormone debate. J Soc Issues 2005;61:159–179.
Hays J, Ockene JK, Brunner RL, et al. for the Women’s Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839–1854.
Brunner RL, Gass M, Aragaki A, et al. for the Women’s Health Initiative Investigators. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: Results from the Women’s Health Initiative Randomized Clinical Trial. Arch Intern Med 2005;165:1976–1986.
Kornblith AB, Herndon JE, Silverman LR, et al. Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A Cancer and Leukemia Group B study. J Clin Oncol 2002;29:2441–2452.
Testa MA, Anderson RB, Nackley JF, et al. Quality of life and antihypertensive therapy in men: A comparison of captopril and enalapril. N Engl J Med 1993;328:901–913.
Shumaker SA, Anderson R, Berzon R, Hayes R (eds.). Special Issue. International use, application and performance of health-related quality of life measures. Qual Life Res 1993;2:376–495.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection. Med Care 1992;30:473–483.
Rabin R, de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann Med 2001;33:337–343.
Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 1993;11:570–579.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365–376.
Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277–299.
Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psych Meas 1977;1:385–401.
McNair DM, Loor M, Droppleman LF. Manual of the Profile of Mood States. San Diego, California: Educational and Industrial Testing Service, 1971.
Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In Wenger NK, Mattson ME, Furberg CD, Elinson J (eds.). Assessment of Quality of Life in Clinical Trials in Cardiovascular Therapies. Washington, DC: Le Jacq Publishing, 1984, pp. 170–183.
Granger CV, Albrecht GL, Hamilton BB. Outcomes of comprehensive medical rehabilitation: Mesurement by PULSES profile and the Barthel Index. Arch Phys Med Rehab 1979;60:145–154.
Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: A reliability study. Intern Disabil Stud 1988;10:61–63.
Hays RD, Hadorn D. Responsiveness to change: An aspect of validity, not a separate dimension. Qual Life Res 1992;1:73–75.
Hays RD, Revicki DA. Reliability and Validity (Including Responsiveness). In Fayers P, Hays R (eds.). Assessing Quality of Life in Clinical Trials (2nd edition). New York: Oxford University Press, 2005.
Cella DF, Wiklund I, Shumaker SA, et al. Integrating health-related quality of life into cross-national clinical trials. Qual Life Res 1993;2:433–440.
Naughton MJ, Shumaker SA, Anderson R, Czajkowski S. Psychological Aspects of Health-Related Quality of Life Measurement: Tests and Scales. In Spilker B (ed.). Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers, 1996.
Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008;61:102–109.
Jaeschke R, Singer J, Guyatt G. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1991;12:266S–269S.
Guyatt G, Walter S, Norman G. Measuring change over time: Assessment the usefulness of evaluative instruments. J Chronic Dis 1987;40:171–178.
Guyatt G, Osoba D, Wu AW. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 2002;77:371–383.
Weinstein MC, Torrance G, McGuire A. QALYs: The basics. Value Health 2009;12:S5–S9.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622–629.
Revicki DA, Kaplan RM. Relationship between psychometric and utility-based approaches to the measurement of health-related quality of life. Qual Life Res 1993;2:477–487.
Torrance GW. Integrating Economic Evaluations and Quality of Life Assessments. In Spilker B (ed.). Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Press, 1996.
Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life Res 1993;2:467–475.
Clark PM, Hayes AJ, Glasziou PG, et al. Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes. Med Care 2009;47:61–68.
Special Issue. Moving the QALY forward: Building a pragmatic road. Value Health 2009;12:S1–S39.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer New York
About this chapter
Cite this chapter
Friedman, L.M., Furberg, C.D., DeMets, D.L. (2010). Assessment of Health-Related Quality of Life. In: Fundamentals of Clinical Trials. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1586-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1586-3_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1585-6
Online ISBN: 978-1-4419-1586-3
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)